Back to search

Article

BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses Among Transplant Recipients Who Had Received Two Doses of CoronaVac

2022-12-07

Abstract excerpt

<h4>Introduction: </h4> We evaluated neutralizing antibody and anti-spike antibody (anti-S) response against omicron variant in solid organ (SOT) or hematopoietic stem cell (HSTC) receivers after third dose of BNT162b2 (BNT) or CoronaVac (CV) following two doses of CV. <h4>Methods: </h4>: In total, 95 participants who underwent SOT (n=62; 44 liver, 18 kidney) or HSCT (n=27; 5 allogeneic, 22 autologous) were inclu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a849f228-d485-5a2f-8ad3-d1ec901fdc15
DOI
10.21203/rs.3.rs-2316160/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses Among Transplant Recipients Who Had Received Two Doses of CoronaVacDOI 10.21203/rs.3.rs-2316160/v1
Select a neighboring publication to make it the new centre.